Phase II study of gemcitabine, oxaliplatin in combination with panitumumab in KRAS wild-type unresectable or metastatic biliary tract and gallbladder cancerAram F. Hezel, Andrew X. Zhu, Jill N. Allen et al.|British Journal of Cancer|2014Cited by 58